Description: Cryosite Limited is a biotechnology and biologics logistics company. The Company is engaged in cryopreservation and expansion of mesenchymal stem cells (MSCs) from umbilical cord tissue. The Company operates through two segments: Individualised Consumer Biologics, and Scientific Processing and Logistics. The Individualised Consumer Biologics segment provides cord tissue MSC banking to parents, and specialized contract good manufacturing practice (GMP) manufacturing and associated consultancy services to therapeutic and regenerative medicine companies involved in the development and commercialization of technologies. The Scientific Processing and Logistics segment provides specialized commercial drug distribution. The Company also provides specialized bio-repository, clinical trials logistics, commercial drug distribution, contract cellular therapies manufacturing and associated consultancy services to commercial clients both within Australia and internationally.
Home Page: www.cryosite.com
CTE Technical Analysis
13a Ferndell Street
South Granville,
NSW
2142
Australia
Phone:
61 2 8865 2000
Officers
| Name | Title |
|---|---|
| Mr. John Hogg | Chief Exec. Officer |
| Ms. Jane Hao | Chief Financial Officer |
| Ms. Kim Bradley-Ware B.Com., CPA, L.L.B. | Company Sec. |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 25.63 |
| Price-to-Book MRQ: | 17.5731 |
| Price-to-Sales TTM: | 2.7816 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 22 |